No, the title is not a cliche.  It's the name of a fabulous organization founded by the daughters of one of my colleagues here at John...

In the past, I've discussed the financial challenges facing those of us who conduct research on rare diseases and the important role pr...

It's a warm, sunny day today.  Spring is finally here, from the looks of things.  That means it's time for a new beginning. On m...

September is Childhood Cancer Awareness Month.  If you are a regular reader of my blog (even if I'm not a regular writer), you are alrea...

Personalized medicine is the new Holy Grail of cancer therapy.  The drugs we currently use are stupid.  They don't actually target ca...

Well, maybe music can't cure cancer, but it can certainly heal the spirit. Drew Seeley released a new song today that he wrote for my ...

 Today was the day. I recently wrote about chemotherapy shortages .  They've been in the news more and more over the past 12 mon...

Avastin has been in the news a lot lately, and most of the press has been negative.  In November, the FDA revoked its approval of Avastin t...

Photo Credit The issue of chemotherapy drug shortages has made the news a lot over the past 6 months or so, including an OpEd piece in ...

The vast majority of biomedical research conducted in the United States is funded by taxpayers through grants distributed by the National In...